Cita APA

Feng, H., Liu, K., Shen, X., Liang, J., Wang, C., Qiu, W., . . . Zhao, R. (2020). Correction: Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5(+) colorectal cancer. Cell Death Dis.

Chicago Style Citation

Feng, Haoran, Kun Liu, Xiaonan Shen, Juyong Liang, Changgang Wang, Weihua Qiu, Xi Cheng, i Ren Zhao. "Correction: Targeting Tumor Cell-derived CCL2 As a Strategy to Overcome Bevacizumab Resistance in ETV5(+) Colorectal Cancer." Cell Death Dis 2020.

Cita MLA

Feng, Haoran, et al. "Correction: Targeting Tumor Cell-derived CCL2 As a Strategy to Overcome Bevacizumab Resistance in ETV5(+) Colorectal Cancer." Cell Death Dis 2020.